This communication does not constitute an offer or invitation to 
subscribe for or purchase any securities of Santhera Pharmaceuticals 
Holding AG. This publication may contain certain forward-looking 
statements concerning the Company and its business. Such statements 
involve certain risks, uncertainties and other factors which could cause 
the actual results, financial condition, performance or achievements of 
the Company to be materially different from those expressed or implied 
by such statements. Readers should therefore not place undue reliance on 
these statements, particularly not in connection with any contract or 
investment decision. The Company disclaims any obligation to update 
these forward-looking statements. 
 
   # # # 
 
 
 
   Attachment 
 
 
   -- 2021 03 03_Vamorolone-LPLV_e_final 
      https://ml-eu.globenewswire.com/Resource/Download/4f1d6fad-83dd-4ee5-9d79-841e7821da9e

(END) Dow Jones Newswires

March 03, 2021 01:00 ET (06:00 GMT)